HIV Medicine

Cover image for Vol. 15 Issue 5

Early View (Online Version of Record published before inclusion in an issue)

Edited By: Brian Gazzard and Jens Lundgren

Impact Factor: 3.155

ISI Journal Citation Reports © Ranking: 2012: 19/70 (Infectious Diseases)

Online ISSN: 1468-1293

VIEW

  1. 1 - 29
  1. Short Communications

  2. Original Research

    1. A comparison of computational models with and without genotyping for prediction of response to second-line HIV therapy

      AD Revell, MA Boyd, D Wang, S Emery, B Gazzard, P Reiss, AI van Sighem, JS Montaner, HC Lane and BA Larder

      Article first published online: 15 APR 2014 | DOI: 10.1111/hiv.12156

  3. Short Communications

    1. Hepatitis B virus surface antigen and anti-hepatitis C virus rapid tests underestimate hepatitis prevalence among HIV-infected patients

      BL Hønge, S Jespersen, C Medina, DS Té, ZJ da Silva, L Østergaard, AL Laursen, C Wejse, H Krarup, C Erikstrup and for the Bissau HIV cohort study group

      Article first published online: 9 APR 2014 | DOI: 10.1111/hiv.12158

  4. Original Research

    1. Prevalence of human papillomavirus in men who have sex with men in the era of an effective vaccine; a call to act

      C Sadlier, D Rowley, D Morley, S Surah, S O'Dea, S Delamere, J O'Leary, P Smyth, S Clarke, O Sheils and C Bergin

      Article first published online: 23 MAR 2014 | DOI: 10.1111/hiv.12150

    2. Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimen

      I Jarrin, B Hernández-Novoa, B Alejos, I Santos, J Lopez-Aldeguer, M Riera, F Gutiérrez, R Rubio, A Antela, JR Blanco, S Moreno and the Cohort of the Spanish HIV Research Network (CoRIS)

      Article first published online: 23 MAR 2014 | DOI: 10.1111/hiv.12144

    3. Lipoprotein-associated phospholipase A2 and cardiovascular disease risk in HIV infection

      A Ross Eckard, CT Longenecker, Y Jiang, SM Debanne, D Labbato, N Storer and GA McComsey

      Article first published online: 20 MAR 2014 | DOI: 10.1111/hiv.12143

  5. Short Communications

    1. The rate of recovery in renal function when patients with HIV infection discontinue treatment with tenofovir

      J Young, Q Wang, CA Fux, E Bernasconi, H Furrer, P Vernazza, A Calmy, M Cavassini, R Weber, M Battegay, HC Bucher and and theSwiss HIV Cohort Study

      Article first published online: 18 MAR 2014 | DOI: 10.1111/hiv.12149

  6. Original Research

    1. Costs of adverse events among patients with HIV infection treated with nonnucleoside reverse transcriptase inhibitors

      KN Simpson, S-Y Chen, AW Wu, L Boulanger, R Chambers, K Nedrow, M Tawadrous, CL Pashos and S Haider

      Article first published online: 18 MAR 2014 | DOI: 10.1111/hiv.12145

    2. Pregnancy complications in HIV-positive women: 11-year data from the Frankfurt HIV Cohort

      A Reitter, AU Stücker, R Linde, C Königs, G Knecht, E Herrmann, R Schlößer, F Louwen and A Haberl

      Article first published online: 6 MAR 2014 | DOI: 10.1111/hiv.12142

    3. Etravirine in treatment-experienced, HIV-1-infected children and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study

      G Tudor-Williams, P Cahn, K Chokephaibulkit, J Fourie, C Karatzios, S Dincq, M Opsomer, TN Kakuda, S Nijs, L Tambuyzer, FL Tomaka and on behalf of the PIANO study group

      Article first published online: 3 MAR 2014 | DOI: 10.1111/hiv.12141

    4. Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon

      M Meresse, L March, C Kouanfack, R-C Bonono, S Boyer, G Laborde-Balen, A Aghokeng, M Suzan-Monti, E Delaporte, B Spire, M-P Carrieri, C Laurent and Stratall ANRS 12110/ESTHER Study Group

      Article first published online: 3 MAR 2014 | DOI: 10.1111/hiv.12140

    5. HIV-associated neurocognitive disorder in HIV-infected Koreans: the Korean NeuroAIDS Project

      NS Ku, Y Lee, JY Ahn, JE Song, MH Kim, SB Kim, SJ Jeong, K-W Hong, E Kim, SH Han, JY Song, HJ Cheong, YG Song, WJ Kim, JM Kim, DM Smith and JY Choi

      Article first published online: 24 FEB 2014 | DOI: 10.1111/hiv.12137

    6. Immune activation despite suppressive highly active antiretroviral therapy is associated with higher risk of viral blips in HIV-1-infected individuals

      A Zoufaly, JG Kiepe, S Hertling, A Hüfner, O Degen, T Feldt, S Schmiedel, M Kurowski and J van Lunzen

      Article first published online: 24 FEB 2014 | DOI: 10.1111/hiv.12134

  7. Reviews

    1. Helping our patients take HIV pre-exposure prophylaxis (PrEP): a systematic review of adherence interventions

      JL Marcus, T Buisker, T Horvath, KR Amico, JD Fuchs, SP Buchbinder, RM Grant and AY Liu

      Article first published online: 24 FEB 2014 | DOI: 10.1111/hiv.12132

  8. Original Research

    1. Efficacy and safety of once-daily maraviroc plus ritonavir-boosted darunavir in pretreated HIV-infected patients in a real-life setting

      J Macías, E Recio, M Márquez, C García, P Jiménez, D Merino, L Muñoz, J Pasquau, G Ojeda, P Bancalero, N Chueca and JA Pineda

      Article first published online: 24 FEB 2014 | DOI: 10.1111/hiv.12129

    2. Multiple hepatitis C virus (HCV) reinfections in HIV-positive men who have sex with men: no influence of HCV genotype switch or interleukin-28B genotype on spontaneous clearance

      P Ingiliz, I Krznaric, H-J Stellbrink, G Knecht, T Lutz, C Noah, H Stocker, M Obermeier, S Dupke, C Boesecke, JK Rockstroh, A Baumgarten and C Hoffmann

      Article first published online: 24 FEB 2014 | DOI: 10.1111/hiv.12127

    3. European mitochondrial haplogroups are not associated with hepatitis C virus (HCV) treatment response in HIV/HCV-coinfected patients

      M Guzmán-Fulgencio, N Rallón, J Berenguer, A Fernández-Rodríguez, V Soriano, P Miralles, MA Jiménez-Sousa, C Restrepo, JC López, M García-Álvarez, T Aldámiz, JM Benito and S Resino

      Article first published online: 24 FEB 2014 | DOI: 10.1111/hiv.12126

    4. Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial

      JE Lake, GA McComsey, T Hulgan, CA Wanke, A Mangili, SL Walmsley, SA Stramotas, R Tracy and JS Currier

      Article first published online: 10 FEB 2014 | DOI: 10.1111/hiv.12128

  9. Short Communications

    1. Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks

      M Bloch, WWY Tong, J Hoy, D Baker, FJ Lee, R Richardson, A Carr and for the TROP (Switch from Tenofovir to Raltegravir for Low Bone Density) study team

      Article first published online: 26 JAN 2014 | DOI: 10.1111/hiv.12123

  10. Original Research

    1. Patients who present late to HIV care and associated risk factors in Nigeria

      PA Agaba, ST Meloni, HM Sule, OO Agbaji, PN Ekeh, GC Job, N Nyango, PO Ugoagwu, GE Imade, JA Idoko and PJ Kanki

      Article first published online: 20 JAN 2014 | DOI: 10.1111/hiv.12125

    2. Impact of maternal hepatitis B virus coinfection on mother-to-child transmission of HIV

      V Mave, D Kadam, A Kinikar, N Gupte, D Bhattacharya, R Bharadwaj, K McIntire, V Kulkarni, U Balasubramanian, N Suryavanshi, C Thio, P Deshpande, J Sastry, R Bollinger, A Gupta, R Bhosale and the SWEN India and Byramjee-Jeejeebhoy Medical College Clinical Trials Unit Study team

      Article first published online: 14 JAN 2014 | DOI: 10.1111/hiv.12120

    3. Community HIV-1 drug resistance is associated with transmitted drug resistance

      MW Tilghman, J Pérez-Santiago, G Osorio, SJ Little, DD Richman, WC Mathews, RH Haubrich and DM Smith

      Article first published online: 12 JAN 2014 | DOI: 10.1111/hiv.12122

    4. Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir

      E Martinez, A Gonzalez-Cordon, E Ferrer, P Domingo, E Negredo, F Gutierrez, J Portilla, A Curran, D Podzamczer, J Murillas, JI Bernardino, I Santos, JA Carton, J Peraire, J Pich, I Perez, JM Gatell and for the ATADAR Study Group

      Article first published online: 12 JAN 2014 | DOI: 10.1111/hiv.12121

    5. Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapy

      G Sampériz, D Guerrero, M López, JL Valera, A Iglesias, Á Ríos, A Campins, E Sala, J Murillas, B Togores, J Palmer, M Rodriguez, JB Soriano, J Sauleda, M Riera and A Agusti

      Article first published online: 8 DEC 2013 | DOI: 10.1111/hiv.12117

  11. Short Communications

    1. Linkage to care following community-based mobile HIV testing compared with clinic-based testing in Umlazi Township, Durban, South Africa

      IV Bassett, S Regan, P Luthuli, H Mbonambi, B Bearnot, A Pendleton, M Robine, D Mukuvisi, H Thulare, RP Walensky, KA Freedberg, E Losina and B Mhlongo

      Article first published online: 19 NOV 2013 | DOI: 10.1111/hiv.12115

    2. Repeat antenatal HIV testing in the third trimester: a study of feasibility and maternal uptake rates

      B Williams, M Costello, E McHugh, M Le Prevost, A Phil-Ebosie, C Tilsed, J McSorley, S Murphy, G Brook and A Williams

      Article first published online: 11 NOV 2013 | DOI: 10.1111/hiv.12110

VIEW

  1. 1 - 29

SEARCH

SEARCH BY CITATION